Skp2 is required for incretin hormone-mediated β-cell proliferation

31Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The glucoincretin hormone glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (Ex-4) promote β-cell growth and expansion. Here we report an essential role for Skp2, a substrate recognition component of SCF (Skp, Cullin, F-box) ubiquitin ligase, in promoting glucoincretin- induced β-cell proliferation by regulating the cellular abundance of p27. In vitro, GLP-1 treatment increases Skp2 levels, which accelerates p27 degradation, whereas in vivo, loss of Skp2 prevents glucoincretin-induced β-cell proliferation. Using inhibitors of phosphatidylinositol 3-kinase and Irs2 silencing RNA, we also show that the effects of GLP-1 in facilitating Skp2-dependent p27 degradation are mediated via the Irs2-phosphatidylinositol-3 kinase pathway. Finally, we show that down-regulation of p27 occurs in islets from aged mice and humans, although in these islets, age-dependent accumulation of p16 Ink4a prevent glucoincretin- induced β-cell proliferation; however, ductal cell proliferation is maintained. Taken together, these data highlight a critical role for Skp2 in glucoincretin-induced β-cell proliferation. © 2011 by The Endocrine Society.

Cite

CITATION STYLE

APA

Tschen, S. I., Georgia, S., Dhawan, S., & Bhushan, A. (2011). Skp2 is required for incretin hormone-mediated β-cell proliferation. Molecular Endocrinology, 25(12), 2134–2143. https://doi.org/10.1210/me.2011-1119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free